[ad_1] Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics, putting a damper on the prospects of a deal for the promising heart-drug…
Tag: Biopharmaceuticals
Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics
[ad_1] Updated Jan. 8, 2024 1:14 pm ET Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as big pharmaceutical companies continue to snap up…
Merck to Buy Harpoon Therapeutics for $680 Million
[ad_1] Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
[ad_1] AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash…
AstraZeneca to Buy Icosavax for Up to $1.1 Bln
[ad_1] AstraZeneca said it would buy U.S.-based clinical-stage biopharmaceutical company Icosavax for up to $1.1 billion in a deal that expands its vaccines and immune therapies late-stage pipeline. The pharmaceutical…
$19 Billion in a Week: AbbVie Makes Two Big Bets
[ad_1] Early last week, AbbVie was on every healthcare investment banker’s list. But with two quick deal announcements under its belt in just six days, AbbVie may have transformed its…
Gene Editing Will Change Medicine—and Maybe Health Investing Too
[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…